- NCIt
- C3042
Loading cancer entity…
Loading cancer entity…
Clinical trials
108 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07755176 | Patient-reported Outcomes Following Percutaneous Ablation of Desmoid Tumors | enrolling by invitation | — | 30 | Mayo ClinicOTHER | 1 | Sep 29, 2026 | clinicaltrials |
| NCT07158892 | Understanding Patient Preferences When Deciding on a Voluntary Musculoskeletal Test | not yet recruiting | N/A | 220 | University of Texas at AustinOTHER | 1 | Sep 22, 2026 | clinicaltrials |
| NCT07170644 |
| A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF) |
| active not recruiting |
| Phase 2 |
| 20 |
| SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, GermanyINDUSTRY |
| 1 |
| Sep 15, 2026 |
| clinicaltrials |
| NCT07176689 | Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) | recruiting | Phase 4 | 50 | SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, GermanyINDUSTRY | 6 | Sep 14, 2026 | clinicaltrials |
| NCT05949099 | Study of Cryoablation and Nirogacestat for Desmoid Tumor | recruiting | Phase 2 | 28 | Nam BuiOTHER | 1 | Sep 10, 2026 | clinicaltrials |
| NCT02402244 | Project: Every Child for Younger Patients With Cancer | recruiting | — | 75,000 | Children's Oncology GroupNETWORK | 6 | Aug 25, 2026 | clinicaltrials |
| NCT04851119 | Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors | recruiting | Phase 1 / Phase 2 | 147 | Children's Oncology GroupNETWORK | 1 | Aug 25, 2026 | clinicaltrials |
| NCT03785964 | Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)(DeFi) | completed | Phase 3 | 142 | SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, GermanyINDUSTRY | 7 | Aug 20, 2026 | clinicaltrials |
| NCT04195399 | A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery | active not recruiting | Phase 2 | 31 | Children's Oncology GroupNETWORK | 5 | Jul 30, 2026 | clinicaltrials |
| NCT06330545 | Radiation Therapy for Dupuytren's Contracture Following Non-Surgical Release | recruiting | N/A | 95 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Jul 28, 2026 | clinicaltrials |
| NCT07227649 | NAC-REPAIR for Post-surgical Pain | not yet recruiting | Phase 2 | 80 | University of ArizonaOTHER | 1 | Jul 17, 2026 | clinicaltrials |
| NCT06248866 | Effect Of Extracorporeal Shock Wave Therapy On Ultrasonography Changes In Patients With Palmar Fibromatosis: A Randomized Controlled Trial(ESWT) | completed | N/A | 60 | Cairo UniversityOTHER | 1 | Jul 14, 2026 | clinicaltrials |
| NCT06151197 | Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)(STRIDE) | completed | Phase 3 | 436 | Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY | 2 | Jul 13, 2026 | clinicaltrials |
| NCT02066181 | Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis | completed | Phase 3 | 87 | National Cancer Institute (NCI)NIH | 2 | Jun 24, 2026 | clinicaltrials |
| NCT07661342 | DEPART Study at Yale(Dupuytren's) | not yet recruiting | Phase 3 | 158 | Yale UniversityOTHER | 1 | Jun 22, 2026 | clinicaltrials |
| NCT02834013 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | active not recruiting | Phase 2 | 798 | National Cancer Institute (NCI)NIH | 2 | Jun 17, 2026 | clinicaltrials |
| NCT07640425 | Safety and Efficacy Study of Collagenase CNT201 Injection for Treatment of Dupuytren's Contracture | recruiting | Phase 1 / Phase 2 | 60 | CONNEXTINDUSTRY | 1 | Jun 12, 2026 | clinicaltrials |
| NCT04871282 | A Study of AL102 in Patients With Progressing Desmoid Tumors(RINGSIDE) | active not recruiting | Phase 2 / Phase 3 | 198 | Immunome, Inc.INDUSTRY | 11 | Jun 8, 2026 | clinicaltrials |
| NCT04281381 | Observing People With Desmoid-Type Fibromatosis | recruiting | — | 100 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT06660121 | Electrochemotherapy for Desmoid Tumors(ECT-DESMO) | withdrawn | — | 0 | Istituto Ortopedico RizzoliOTHER | 1 | May 14, 2026 | clinicaltrials |
| NCT05041036 | Individual Patient Compassionate Use of Nirogacestat | available | — | — | SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, GermanyINDUSTRY | 0 | May 8, 2026 | clinicaltrials |
| NCT07541430 | A Study in Adults With Desmoid Tumors | recruiting | Phase 2 | 50 | Elpiscience (Suzhou) Biopharma, Ltd.INDUSTRY | 1 | Apr 30, 2026 | clinicaltrials |
| NCT03192020 | Trial Comparing Treatment Strategies in Dupuytren's Contracture(DETECT) | active not recruiting | Phase 4 | 302 | Tampere UniversityOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT02867033 | National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES)(ALTITUDES) | active not recruiting | N/A | 628 | Centre Oscar LambretOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT05152173 | Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis | completed | Phase 2 | 176 | Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY | 1 | Mar 27, 2026 | clinicaltrials |
| NCT07496242 | Immunological Phenotype of Desmoid-fibromatosis-affected Patients. | recruiting | — | 200 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 2 | Mar 27, 2026 | clinicaltrials |
| NCT04122313 | Post-contracture Release Radiation for Dupuytren's Disease | recruiting | — | 50 | University of MinnesotaOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT03155854 | The Effects of Prophylactic Limited Palmar Fasciectomy on Surgical Outcomes and Scarring | recruiting | N/A | 50 | Mayo ClinicOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT07461246 | Familial Adenomatous Poliposys Italian Network (Rete Italiana Poliposi Adenomatosa Familiare)(RIPAF) | active not recruiting | — | 1,500 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT07443371 | Effect of Transfer Energy Capacitive and Resistive Therapy on Palmar Fibromatosis | not yet recruiting | N/A | 36 | Cairo UniversityOTHER | 1 | Mar 2, 2026 | clinicaltrials |
| NCT05111964 | HIFU Ablation of Soft Tissue Sarcoma(SarcAblate) | recruiting | N/A | 10 | Oxford University Hospitals NHS TrustOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT02476305 | Evaluation of the Cryodestruction of Non Abdominopelvic Desmoid Tumors in Patients Progressing Despite Medical Treatment(CRYODESMO01) | completed | N/A | 50 | University Hospital, Strasbourg, FranceOTHER | 1 | Jan 20, 2026 | clinicaltrials |
| NCT06081400 | Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful Waiting(CRYODESMO-02) | recruiting | N/A | 150 | University Hospital, Strasbourg, FranceOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT07180524 | Prospective Clinical Trial on the Impact of Uterine Firomatosis on Pelvic Floor. | recruiting | — | 200 | Fondazione IRCCS Policlinico San Matteo di PaviaOTHER | 1 | Sep 18, 2025 | clinicaltrials |
| NCT06945887 | Treatment of Desmoid Fibromatosis With Arterial Embolization(TAE-DESMO) | recruiting | — | 20 | Istituto Ortopedico RizzoliOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT02547831 | Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients | completed | — | 100 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Sep 11, 2025 | clinicaltrials |
| NCT06258421 | Burden of Disease and Living Situation in Desmoid Patients(PROSa Desmoid) | completed | — | 100 | Technische Universität DresdenOTHER | 1 | Aug 24, 2025 | clinicaltrials |
| NCT03407820 | Nylon Versus Chromic Gut Sutures for Minor Hand Surgery | completed | N/A | 112 | University of Texas at AustinOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT02228889 | RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction | completed | N/A | 46 | Jeffrey JanisOTHER | 1 | Jun 6, 2025 | clinicaltrials |
| NCT05254457 | Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis | completed | Phase 3 | 145 | Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY | 1 | Mar 21, 2025 | clinicaltrials |
| NCT04874870 | Effectiveness of Splinting After Collagenase Injection | completed | Phase 3 | 80 | Foundation for Orthopaedic Research and EducationOTHER | 1 | Feb 26, 2025 | clinicaltrials |
| NCT03190174 | Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers | completed | Phase 1 / Phase 2 | 34 | Sarcoma Oncology Research Center, LLCOTHER | 1 | Feb 17, 2025 | clinicaltrials |
| NCT06806410 | The Efficacy of Liposomal Bupivacaine in Ultrasound Guided Supraclavicular Nerve Blocks for Hand and Wrist Surgery | active not recruiting | Phase 4 | 120 | St. Luke's Hospital, PennsylvaniaOTHER | 1 | Feb 6, 2025 | clinicaltrials |
| NCT06788847 | Evaluating Ultrasound-Guided Needle Knife for Dupuytren's Contracture(DC-US) | recruiting | N/A | 30 | Mohamed Maher Ismail Ahmed ElashmawyOTHER | 1 | Jan 27, 2025 | clinicaltrials |
| NCT02076906 | MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors | completed | Phase 1 | 7 | AeRang KimOTHER | 1 | Jan 1, 2025 | clinicaltrials |
| NCT05300893 | Effectiveness of Night Splinting After Percutaneous Needle Fasciotomy in Dupuytren's Contracture | recruiting | N/A | 154 | Uppsala UniversityOTHER | 1 | May 31, 2024 | clinicaltrials |
| NCT03802084 | A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor | completed | Phase 1 / Phase 2 | 24 | Hyo Song KimOTHER | 1 | May 13, 2024 | clinicaltrials |
| NCT05877066 | Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture(GRASP-DC) | terminated | — | 130 | Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY | 1 | Apr 16, 2024 | clinicaltrials |
| NCT06355921 | A Prospective Clinical Study on the Safety and Efficacy of Radiofrequency Ablation for the Treatment of Patients With Desmoid Tumors(RFAdesmoid) | not yet recruiting | N/A | 27 | Blokhin's Russian Cancer Research CenterOTHER | 1 | Apr 10, 2024 | clinicaltrials |
| NCT03507010 | Ledderhose Disease: Radiotherapy or Not?(LedRad) | active not recruiting | Phase 3 | 84 | University Medical Center GroningenOTHER | 1 | Feb 28, 2024 | clinicaltrials |
Data updated 9 hours agoSource updated Sep 29, 2026source: clinicaltrials